Cost-effectiveness Of Cetuximab In Metastatic Colorectal Cancer
Friday, August 7, 2009 - 16:28
in Health & Medicine
From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a new study.